Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working GroupFernanda Mosele, Fabrice André|Annals of Oncology|2020Cited by 1.2k
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Fabrice André|Nature Medicine|2023Cited by 351